| |
| |
|
| Insider
Information: |
Berg Jeffrey Alan |
| Relationship: |
10% Owner |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
12,346 |
|
|
Indirect Shares
|
276,100 |
|
|
| Direct
Value |
$23,457 |
|
|
|
Indirect Value
|
$524,590 |
|
|
| Total
Shares |
288,446 |
|
|
| Total
Value |
$548,047 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eterna Therapeutics Inc |
ERNA |
10% Owner |
2020-06-03 |
12,346 |
2020-06-03 |
276,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-06-03 |
4 |
S |
$1.10 |
$24,059 |
I/I |
(21,932) |
276,100 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-06-02 |
4 |
S |
$0.99 |
$30,423 |
I/I |
(30,730) |
297,440 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-06-01 |
4 |
S |
$1.06 |
$31,770 |
I/I |
(30,000) |
328,170 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-05-29 |
4 |
S |
$1.06 |
$26,450 |
I/I |
(25,000) |
358,170 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-05-28 |
4 |
S |
$1.08 |
$13,350 |
I/I |
(12,338) |
383,170 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-05-27 |
4 |
S |
$1.11 |
$5,540 |
I/I |
(5,000) |
395,508 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2020-05-26 |
4 |
S |
$1.09 |
$21,780 |
I/I |
(20,000) |
400,508 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-12-23 |
4 |
S |
$2.45 |
$490 |
I/I |
(200) |
421,100 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
10% Owner |
– – • |
2019-12-20 |
4 |
S |
$2.72 |
$4,624 |
I/I |
(1,700) |
421,300 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
919 |
12,346 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2016-11-16 |
4 |
B |
$7.21 |
$28,374 |
I/I |
3,920 |
423,000 |
2.25 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2016-11-15 |
4 |
B |
$7.33 |
$3,665 |
I/I |
500 |
419,080 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2016-11-14 |
4 |
B |
$7.20 |
$8,640 |
I/I |
1,200 |
418,580 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2016-08-12 |
4 |
B |
$5.25 |
$21,480 |
I/I |
4,000 |
417,380 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2015-06-10 |
4 |
B |
$0.26 |
$6,700 |
I/I |
25,000 |
20,668,982 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2015-06-09 |
4 |
B |
$0.28 |
$2,789 |
I/I |
10,000 |
20,643,982 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2015-06-08 |
4 |
B |
$0.27 |
$8,209 |
I/I |
30,000 |
20,633,982 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2015-05-28 |
4 |
B |
$0.31 |
$3,076 |
I/I |
10,000 |
20,603,982 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • • |
2014-09-19 |
4 |
B |
$0.35 |
$6,310 |
I/I |
18,095 |
20,593,982 |
2.17 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Director |
– • – |
2014-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
530,000 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Interim CEO |
• • • |
2012-12-18 |
4 |
B |
$0.20 |
$691,726 |
I/I |
3,458,629 |
20,575,887 |
2.64 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Interim CEO |
• • • |
2012-12-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
17,117,258 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
INTERIM CEO |
• • • |
2012-09-19 |
4 |
B |
$0.19 |
$1,908 |
I/I |
10,000 |
17,217,258 |
2.56 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
INTERIM CEO |
• • • |
2012-09-13 |
4 |
B |
$0.20 |
$305 |
I/I |
1,500 |
17,207,258 |
2.56 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
INTERIM CEO |
• • • |
2012-09-11 |
4 |
B |
$0.19 |
$9,878 |
I/I |
52,000 |
17,205,758 |
2.56 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
